Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease

References

• Abello N, Kerstjens HA, Postma DS, Bischoff R. 2009. Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. J Proteome Res. 8(7):3222–3238.
   PubMed Web of Science ®Google Scholar
• Aitken AE, Lee CM, Morgan ET. 2008. Roles of nitric oxide in inflammatory downregulation of human cytochromes P450. Free Radic Biol Med. 44(6):1161–1168.
   PubMed Web of Science ®Google Scholar
• Aitken AE, Morgan ET. 2007. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab Dispos. 35(9):1687–1693.
   PubMed Web of Science ®Google Scholar
• Aitken AE, Richardson TA, Morgan ET. 2006. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol. 46:123–149.
   PubMed Web of Science ®Google Scholar
• Albertolle ME, Kim D, Nagy LD, Yun CH, Pozzi A, Savas U, Johnson EF, Guengerich FP. 2017. Heme-thiolate sulfenylation of human cytochrome P450 4A11 functions as a redox switch for catalytic inhibition. J Biol Chem. 292(27):11230–11242.
   PubMed Web of Science ®Google Scholar
• Albertolle ME, Phan TTN, Pozzi A, Guengerich FP. 2018. Sulfenylation of human liver and kidney microsomal cytochromes P450 and other drug-metabolizing enzymes as a response to redox alteration. Mol Cell Proteomics. 17(5):889–900.
   PubMed Web of Science ®Google Scholar
• Ashino T, Oguro T, Shioda S, Horai R, Asano M, Sekikawa K, Iwakura Y, Numazawa S, Yoshida T. 2004. Involvement of interleukin-6 and tumor necrosis factor alpha in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guerin and lipopolysaccharide in mouse liver. Drug Metab Dispos. 32(7):707–714.
   PubMed Web of Science ®Google Scholar
• Aulak KS, Koeck T, Crabb JW, Stuehr DJ. 2004. Dynamics of protein nitration in cells and mitochondria. Am J Physiol Heart Circ Physiol. 286(1):H30–H38.
   PubMed Web of Science ®Google Scholar
• Aulak KS, Miyagi M, Yan L, West KA, Massillon D, Crabb JW, Stuehr DJ. 2001. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci USA. 98(21):12056–12061.
   PubMed Web of Science ®Google Scholar
• Barakat MM, El-Kadi AO, Du Souich P. 2001. L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction. Life Sci. 69(13):1559–1571.
   PubMed Web of Science ®Google Scholar
• Billiar TR, Hoffman RA, Curran RD, Langrehr JM, Simmons RL. 1992. A role for inducible nitric oxide biosynthesis in the liver in inflammation and in the allogeneic immune response. J Lab Clin Med. 120(2):192–197.
   PubMed Web of Science ®Google Scholar
• Blobner M, Kochs E, Fink H, Mayer B, Veihelmann A, Brill T, Stadler J. 1999. Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine. Anesthesiology. 91(4):999–1005.
   PubMed Web of Science ®Google Scholar
• Bredt DS, Snyder SH. 1994. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 63:175–195.
   PubMed Web of Science ®Google Scholar
• Broniowska KA, Diers AR, Hogg N. 2013. S-nitrosoglutathione. Biochim Biophys Acta. 1830(5):3173–3181.
   PubMed Web of Science ®Google Scholar
• Carcillo JA, Doughty L, Kofos D, Frye RF, Kaplan SS, Sasser H, Burckart GJ. 2003. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med. 29(6):980–984.
   PubMed Web of Science ®Google Scholar
• Carlson TJ, Billings RE. 1996. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Mol Pharmacol. 49(5):796–801.
   PubMed Web of Science ®Google Scholar
• Cerrone Jr J, Lee CM, Mi T, Morgan ET. 2020. Nitric oxide mediated degradation of CYP2A6 via the ubiquitin-proteasome pathway in human hepatoma cells. Drug Metab Dispos. 48(7):544–552.
   PubMed Web of Science ®Google Scholar
• Chamulitrat W, Jordan SJ, Mason RP, Litton AL, Wilson JG, Wood ER, Wolberg G, Vedia LMY. 1995. Targets of nitric oxide in a mouse model of liver inflammation by Corynebacterium parvum. Arch Biochem Biophys. 316(1):30–37.
   PubMed Web of Science ®Google Scholar
• Charles KA, Rivory LP, Brown SL, Liddle C, Clarke SJ, Robertson GR. 2006. Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer. Clin Cancer Res. 12(24):7492–7497.
   PubMed Web of Science ®Google Scholar
• Chen D, Lepar G, Kemper B. 1994. A transcriptional regulatory element common to a large family of hepatic cytochrome P450 genes is a functional binding site of the orphan receptor HNF-4. J Biol Chem. 269(7):5420–5427.
   PubMed Web of Science ®Google Scholar
• Claiborne A, Mallett TC, Yeh JI, Luba J, Parsonage D. 2001. Structural, redox, and mechanistic parameters for cysteine-sulfenic acid function in catalysis and regulation. Adv Protein Chem. 58:215–276.
   PubMedGoogle Scholar
• Correia MA, Sadeghi S, Mundo-Paredes E. 2005. Cytochrome P450 ubiquitination: Branding for the proteolytic slaughter? Annu Rev Pharmacol Toxicol. 45:439–464.
   PubMed Web of Science ®Google Scholar
• Correia MA, Wang Y, Kim SM, Guan S. 2014. Hepatic cytochrome P450 ubiquitination: conformational phosphodegrons for E2/E3 recognition? IUBMB Life. 66(2):78–88.
   PubMed Web of Science ®Google Scholar
• Cotman M, Jezek D, Fon Tacer K, Frangez R, Rozman D. 2004. A functional cytochrome P450 lanosterol 14 alpha-demethylase CYP51 enzyme in the acrosome: transport through the Golgi and synthesis of meiosis-activating sterols. Endocrinology. 145(3):1419–1426.
   PubMed Web of Science ®Google Scholar
• Coutant DE, Hall SD. 2018. Disease–drug interactions in inflammatory states via effects on CYP-mediated drug clearance. J Clin Pharmacol. 58(7):849–863.
   PubMed Web of Science ®Google Scholar
• Curran RD, Billiar TR, Stuehr DJ, Ochoa JB, Harbrecht BG, Flint SG, Simmons RL. 1990. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg. 212(4):462–469. discussion 470–461.
   PubMed Web of Science ®Google Scholar
• Davis KL, Martin E, Turko IV, Murad F. 2001. Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol. 41:203–236.
   PubMed Web of Science ®Google Scholar
• Diatchenko L, Romanov S, Malinina I, Clarke J, Tchivilev I, Li X, Makarov SS. 2005. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes. J Leukoc Biol. 78(6):1366–1377.
   PubMed Web of Science ®Google Scholar
• Donato MT, Guillen MI, Jover R, Castell JV, Gomez-Lechon MJ. 1997. Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes. J Pharmacol Exp Ther. 281(1):484–490.
   PubMed Web of Science ®Google Scholar
• Doulias PT, Greene JL, Greco TM, Tenopoulou M, Seeholzer SH, Dunbrack RL, Ischiropoulos H. 2010. Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation. Proc Natl Acad Sci USA. 107(39):16958–16963.
   PubMed Web of Science ®Google Scholar
• Duarte MI, Andrade HF, Jr., Mariano ON, Corbett CE, Sesso A. 1989. Baseline volume data of human liver parenchymal cell. J Submicrosc Cytol Pathol. 21(2):275–279.
   PubMedGoogle Scholar
• Eum HA, Yeom DH, Lee SM. 2006. Role of nitric oxide in the inhibition of liver cytochrome P450 during sepsis. Nitric Oxide. 15(4):423–431.
   PubMed Web of Science ®Google Scholar
• Faouzi S, Medzihradszky KF, Hefner C, Maher JJ, Correia MA. 2007. Characterization of the physiological turnover of native and inactivated cytochromes P450 3A in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97?. Biochemistry. 46(26):7793–7803.
   PubMed Web of Science ®Google Scholar
• Ferrari L, Peng N, Halpert JR, Morgan ET. 2001. Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes. Mol Pharmacol. 60(1):209–216.
   PubMed Web of Science ®Google Scholar
• Ford PC, Wink DA, Stanbury DM. 1993. Autoxidation kinetics of aqueous nitric oxide. FEBS Lett. 326(1–3):1–3.
   PubMed Web of Science ®Google Scholar
• Franco SJ, Huttenlocher A. 2005. Regulating cell migration: calpains make the cut. J Cell Sci. 118(Pt 17):3829–3838.
   PubMed Web of Science ®Google Scholar
• Fruh K, Yang Y. 1999. Antigen presentation by MHC class I and its regulation by interferon gamma. Curr Opin Immunol. 11(1):76–81.
   PubMed Web of Science ®Google Scholar
• Gaston BM, Carver J, Doctor A, Palmer LA. 2003. S-nitrosylation signaling in cell biology. Mol Interv. 3(5):253–263.
   PubMedGoogle Scholar
• Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL, Billiar TR. 1993. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci Usa. 90(2):522–526.
   PubMed Web of Science ®Google Scholar
• Gergel D, Misik V, Riesz P, Cederbaum AI. 1997. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. Arch Biochem Biophys. 337(2):239–250.
   PubMed Web of Science ®Google Scholar
• Gharavi N, El-Kadi AO. 2007. Role of nitric oxide in downregulation of cytochrome P450 1a1 and NADPH: Quinone oxidoreductase 1 by tumor necrosis factor-alpha and lipopolysaccharide. J Pharm Sci. 96(10):2795–2807.
   PubMed Web of Science ®Google Scholar
• Gould N, Doulias PT, Tenopoulou M, Raju K, Ischiropoulos H. 2013. Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J Biol Chem. 288(37):26473–26479.
   PubMed Web of Science ®Google Scholar
• Gow AJ, Duran D, Malcolm S, Ischiropoulos H. 1996. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett. 385(1–2):63–66.
   PubMed Web of Science ®Google Scholar
• Halder SK, Fink M, Waterman MR, Rozman D. 2002. A cAMP-responsive element binding site is essential for sterol regulation of the human lanosterol 14alpha-demethylase gene (CYP51). Mol Endocrinol. 16(8):1853–1863.
   PubMedGoogle Scholar
• Hara H, Adachi T. 2002. Contribution of hepatocyte nuclear factor-4 to down-regulation of CYP2D6 gene expression by nitric oxide. Mol Pharmacol. 61(1):194–200.
   PubMed Web of Science ®Google Scholar
• Hara H, Mitani N, Adachi T. 2000. Inhibitory effect of nitric oxide on the induction of cytochrome P450 3A4 mRNA by 1,25-dihydroxyvitamin D3 in Caco-2 cells. Free Radic Res. 33(3):279–285.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. 2008. Shared principles in NF-kappaB signaling. Cell. 132(3):344–362.
   PubMed Web of Science ®Google Scholar
• Hodgson PD, Renton KW. 1994. Effect of nitro-L-arginine and nitric oxide generators on the down regulation of cytochrome P450. Can J Physiol Pharmacol. 72(suppl.1):P12.13.21.
   Google Scholar
• Huan JY, Streicher JM, Bleyle LA, Koop DR. 2004. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. Toxicol Appl Pharmacol. 199(3):332–343.
   PubMed Web of Science ®Google Scholar
• Ibáñez-Vea M, Huang H, Martínez de Morentin X, Pérez E, Gato M, Zuazo M, Arasanz H, Fernández-Irigoyen J, Santamaría E, Fernandez-Hinojal G, et al. 2018. Characterization of macrophage endogenous S-nitrosoproteome using a cysteine-specific phosphonate adaptable tag in combination with TiO2 chromatography. J Proteome Res. 17(3):1172–1182.
   PubMed Web of Science ®Google Scholar
• Ibeanu GC, Goldstein JA. 1995. Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry. 34(25):8028–8036.
   PubMed Web of Science ®Google Scholar
• Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH. 2001. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol. 3(2):193–197.
   PubMed Web of Science ®Google Scholar
• Jones AE, Brown KC, Werner RE, Gotzkowsky K, Gaedigk A, Blake M, Hein DW, van der Horst C, Kashuba AD. 2010. Variability in drug metabolizing enzyme activity in HIV-infected patients. Eur J Clin Pharmacol. 66(5):475–485.
   PubMed Web of Science ®Google Scholar
• Jover R, Bort R, Gomez-Lechon MJ, Castell JV. 2001. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology. 33(3):668–675.
   PubMed Web of Science ®Google Scholar
• Jung C, Bec N, Lange R. 2002. Substrates modulate the rate-determining step for CO binding in cytochrome P450cam (CYP101). A high-pressure stopped-flow study. Eur J Biochem. 269(12):2989–2996.
   PubMedGoogle Scholar
• Karkhanis A, Hong Y, Chan ECY. 2017. Inhibition and inactivation of human CYP2J2: implications in cardiac pathophysiology and opportunities in cancer therapy. Biochem Pharmacol. 135:12–21.
   PubMed Web of Science ®Google Scholar
• Keefer LK, Nims RW, Davies KM, Wink DA. 1996. “NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms . Meth Enzymol. 268:281–293.
   PubMed Web of Science ®Google Scholar
• Khatsenko O, Kikkawa Y. 1997. Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver. J Pharmacol Exp Ther. 280(3):1463–1470.
   PubMed Web of Science ®Google Scholar
• Khatsenko OG, Gross SS, Rifkind AB, Vane JR. 1993. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA. 90(23):11147–11151.
   PubMed Web of Science ®Google Scholar
• Kim S, Wing SS, Ponka P. 2004. S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. Mol Cell Biol. 24(1):330–337.
   PubMed Web of Science ®Google Scholar
• Kim SM, Acharya P, Engel JC, Correia MA. 2010. Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance. J Biol Chem. 285(46):35866–35877.
   PubMed Web of Science ®Google Scholar
• Kim YM, Bergonia HA, Muller C, Pitt BR, Watkins WD, Lancaster JR. Jr. 1995. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem. 270(11):5710–5713.
   PubMed Web of Science ®Google Scholar
• Kincaid MM, Cooper AA. 2007. ERADicate ER stress or die trying. Antioxid Redox Signal. 9(12):2373–2387.
   PubMed Web of Science ®Google Scholar
• Kitaichi K, Nakayama H, Ueyama J, Nadai M, Baba K, Takagi K, Takagi K, Ohta M, Hasegawa T. 2004. Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7. Biochem Pharmacol. 67(8):1427–1435.
   PubMed Web of Science ®Google Scholar
• Kitaichi K, Wang L, Takagi K, Iwase M, Shibata E, Nadai M, Hasegawa T. 1999. Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide. Antimicrob Agents Chemother. 43(11):2697–2701.
   PubMed Web of Science ®Google Scholar
• Kotamraju S, Matalon S, Matsunaga T, Shang T, Hickman-Davis JM, Kalyanaraman B. 2006. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radic Biol Med. 40(6):1034–1044.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Aretha CW, Geddes TJ. 1999. Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration. J Neurosci. 19(23):10289–10294.
   PubMed Web of Science ®Google Scholar
• Lancaster JR. Jr. 2006. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol. 19(9):1160–1174.
   PubMed Web of Science ®Google Scholar
• Lee CM, Kim BY, Li L, Morgan ET. 2008. Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. J Biol Chem. 283(2):889–898.
   PubMed Web of Science ®Google Scholar
• Lee CM, Kumar V, Riley RI, Morgan ET. 2010. Metabolism and action of proteasome inhibitors in primary human hepatocytes. Drug Metab Dispos. 38(12):2166–2172.
   PubMed Web of Science ®Google Scholar
• Lee CM, Lee BS, Arnold SL, Isoherranen N, Morgan ET. 2014. Nitric oxide and interleukin-1beta stimulate the proteasome-independent degradation of the retinoic acid hydroxylase CYP2C22 in primary rat hepatocytes. J Pharmacol Exp Ther. 348(1):141–152.
   PubMed Web of Science ®Google Scholar
• Lee CM, Pohl J, Morgan ET. 2009. Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures. Drug Metab Dispos. 37(4):865–872.
   PubMed Web of Science ®Google Scholar
• Lee CM, Sun H, Morgan ET. 2011. Probing the mechanism of NO-dependent degradation of CYP2B1. Abstract presented at the international conference on cytochrome P450; Manchester UK.
   Google Scholar
• Lee CM, Tripathi S, Morgan ET. 2017. Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system. Free Radic Biol Med. 108:478–486.
   PubMed Web of Science ®Google Scholar
• Lee CM, Wilderman PR, Park JW, Murphy TJ, Morgan ET. 2020. Tyrosine nitration contributes to nitric oxide-stimulated degradation of CYP2B6. Mol Pharmacol. 98(3):267–279.
   PubMed Web of Science ®Google Scholar
• Lee YI, Giovinazzo D, Kang HC, Lee Y, Jeong JS, Doulias PT, Xie Z, Hu J, Ghasemi M, Ischiropoulos H, et al. 2014. Protein microarray characterization of the S-nitrosoproteome. Mol Cell Proteomics. 13(1):63–72.
   PubMed Web of Science ®Google Scholar
• Liddle C, Mode A, Legraverend C, Gustafsson JA. 1992. Constitutive expression and hormonal regulation of male sexually differentiated cytochromes P450 in primary cultured rat hepatocytes. Arch Biochem Biophys. 298(1):159–166.
   PubMed Web of Science ®Google Scholar
• Li-Masters T, Morgan ET. 2002. Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase. Biochem Pharmacol. 64(12):1703–1711.
   PubMed Web of Science ®Google Scholar
• Lin HL, Kent UM, Zhang H, Waskell L, Hollenberg PF. 2003. Mutation of tyrosine 190 to alanine eliminates the inactivation of cytochrome P450 2B1 by peroxynitrite. Chem Res Toxicol. 16(2):129–136.
   PubMed Web of Science ®Google Scholar
• Lin HL, Myshkin E, Waskell L, Hollenberg PF. 2007. Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation. Chem Res Toxicol. 20(11):1612–1622.
   PubMed Web of Science ®Google Scholar
• Lin HL, Zhang H, Waskell L, Hollenberg PF. 2005. The highly conserved Glu149 and Tyr190 residues contribute to peroxynitrite-mediated nitrotyrosine formation and the catalytic activity of cytochrome P450 2B1. Chem Res Toxicol. 18(8):1203–1210.
   PubMed Web of Science ®Google Scholar
• Liu X, Van Vleet T, Schnellmann RG. 2004. The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol. 44:349–370.
   PubMed Web of Science ®Google Scholar
• Liu Z, Dai X, Zhu H, Zhang M, Zou MH. 2015. Lipopolysaccharides promote S-nitrosylation and proteasomal degradation of liver kinase B1 (LKB1) in macrophages in vivo. J Biol Chem. 290(31):19011–19017.
   PubMed Web of Science ®Google Scholar
• Marletta MA. 1993. Nitric oxide synthase structure and mechanism. J Biol Chem. 268(17):12231–12234.
   PubMed Web of Science ®Google Scholar
• Marshall HE, Merchant K, Stamler JS. 2000. Nitrosation and oxidation in the regulation of gene expression. Faseb J. 14(13):1889–1900.
   PubMed Web of Science ®Google Scholar
• Matthews JR, Botting CH, Panico M, Morris HR, Hay RT. 1996. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 24(12):2236–2242.
   PubMed Web of Science ®Google Scholar
• Miersch S, Mutus B. 2005. Protein S-nitrosation: biochemistry and characterization of protein thiol-NO interactions as cellular signals. Clin Biochem. 38(9):777–791.
   PubMed Web of Science ®Google Scholar
• Minamiyama Y, Imaoka S, Takemura S, Okada S, Inoue M, Funae Y. 2001. Escape from tolerance of organic nitrate by induction of cytochrome P450. Free Radic Biol Med. 31(11):1498–1508.
   PubMed Web of Science ®Google Scholar
• Minamiyama Y, Takemura S, Imaoka S, Funae Y, Tanimoto Y, Inoue M. 1997. Irreversible inhibition of cytochrome P450 by nitric oxide. J Pharmacol Exp Ther. 283(3):1479–1485.
   PubMed Web of Science ®Google Scholar
• Minamiyama Y, Takemura S, Yamasaki K, Hai S, Hirohashi K, Funae Y, Okada S. 2004. Continuous administration of organic nitrate decreases hepatic cytochrome P450. J Pharmacol Exp Ther. 308(2):729–735.
   PubMed Web of Science ®Google Scholar
• Mooradian DL, Hutsell TC, Keefer LK. 1995. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol. 25(4):674–678.
   PubMed Web of Science ®Google Scholar
• Morel Y, Barouki R. 1999. Repression of gene expression by oxidative stress. Biochem J. 342(Pt 3):481–496.
   PubMed Web of Science ®Google Scholar
• Morgan ET. 2017. Chapter 2, Regulation of drug-metabolizing enzymes and drug metabolism by inflammatory responses. In Xie W, editor. Drug metabolism in diseases. Boston, MA: Academic Press; p. 21–58.
   Google Scholar
• Morris SM, Jr., Billiar TR. 1994. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol. 266(6 Pt 1):E829–E839.
   PubMed Web of Science ®Google Scholar
• Muller CM, Scierka A, Stiller RL, Kim YM, Cook DR, Lancaster JR, Jr., Buffington CW, Watkins WD. 1996. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin. Anesthesiology. 84(6):1435–1442.
   PubMed Web of Science ®Google Scholar
• Nakano R, Sato H, Watanabe A, Ito O, Shimizu T. 1996. Conserved Glu318 at the cytochrome P450 1A2 distal site is crucial in the nitric oxide complex stability. J Biol Chem. 271(15):8570–8574.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Puga A, Vasiliou V. 1993. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann N Y Acad Sci. 685:624–640.
   PubMed Web of Science ®Google Scholar
• Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J, Simmons RL. 1992. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med. 176(1):261–264.
   PubMed Web of Science ®Google Scholar
• Ohsumi Y. 2014. Historical landmarks of autophagy research. Cell Res. 24(1):9–23.
   PubMed Web of Science ®Google Scholar
• Ono Y, Saido TC, Sorimachi H. 2016. Calpain research for drug discovery: challenges and potential. Nat Rev Drug Discov. 15(12):854–876.
   PubMed Web of Science ®Google Scholar
• Ouellet H, Lang J, Couture M, Ortiz de Montellano PR. 2009. Reaction of Mycobacterium tuberculosis cytochrome P450 enzymes with nitric oxide. Biochemistry. 48(5):863–872.
   PubMed Web of Science ®Google Scholar
• Park JW, Byrd A, Lee CM, Morgan ET. 2017. Nitric oxide stimulates cellular degradation of human CYP51A1, the highly conserved lanosterol 14alpha-demethylase. Biochem J. 474(19):3241–3252.
   PubMed Web of Science ®Google Scholar
• Park JW, Lee CM, Cheng JS, Morgan ET. 2018. Posttranslational regulation of CYP2J2 by nitric oxide. Free Radic Biol Med. 121:149–156.
   PubMed Web of Science ®Google Scholar
• Pilz RB, Casteel DE. 2003. Regulation of gene expression by cyclic GMP. Circ Res. 93(11):1034–1046.
   PubMed Web of Science ®Google Scholar
• Quaroni LG, Seward HE, McLean KJ, Girvan HM, Ost TW, Noble MA, Kelly SM, Price NC, Cheesman MR, Smith WE, et al. 2004. Interaction of nitric oxide with cytochrome P450 BM3. Biochemistry. 43(51):16416–16431.
   PubMed Web of Science ®Google Scholar
• Radi R. 2004. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA. 101(12):4003–4008.
   PubMed Web of Science ®Google Scholar
• Rafikov R, Dimitropoulou C, Aggarwal S, Kangath A, Gross C, Pardo D, Sharma S, Jezierska-Drutel A, Patel V, Snead C, et al. 2014. Lipopolysaccharide-induced lung injury involves the nitration-mediated activation of RhoA. J Biol Chem. 289(8):4710–4722.
   PubMed Web of Science ®Google Scholar
• Raynes R, Pomatto LC, Davies KJ. 2016. Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways. Mol Aspects Med. 50:41–55.
   PubMed Web of Science ®Google Scholar
• Renton KW. 2001. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther. 92(2-3):147–163.
   PubMed Web of Science ®Google Scholar
• Roberts ES, Lin H, Crowley JR, Vuletich JL, Osawa Y, Hollenberg PF. 1998. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1. Chem Res Toxicol. 11(9):1067–1074.
   PubMed Web of Science ®Google Scholar
• Rozman D, Cotman M, Frangez R. 2002. Lanosterol 14alpha-demethylase and MAS sterols in mammalian gametogenesis. Mol Cell Endocrinol. 187(1–2):179–187.
   PubMed Web of Science ®Google Scholar
• Rozman D, Fink M, Fimia GM, Sassone-Corsi P, Waterman MR. 1999. Cyclic adenosine 3',5'-monophosphate(cAMP)/cAMP-responsive element modulator (CREM)-dependent regulation of cholesterogenic lanosterol 14alpha-demethylase (CYP51) in spermatids. Mol Endocrinol. 13(11):1951–1962.
   PubMedGoogle Scholar
• Schmid D, Munz C. 2007. Innate and adaptive immunity through autophagy. Immunity. 27(1):11–21.
   PubMed Web of Science ®Google Scholar
• Scott EE, White MA, He YA, Johnson EF, Stout CD, Halpert JR. 2004. Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding. J Biol Chem. 279(26):27294–27301.
   PubMed Web of Science ®Google Scholar
• Secor McVoy JR, Oughli HA, Oh U. 2015. Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2. J Neuroinflammation. 12:27.
   PubMed Web of Science ®Google Scholar
• Sewer MB, Barclay TB, Morgan ET. 1998. Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene. Mol Pharmacol. 54(2):273–279.
   PubMed Web of Science ®Google Scholar
• Sewer MB, Morgan ET. 1997. Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes. Biochem Pharmacol. 54(6):729–737.
   PubMed Web of Science ®Google Scholar
• Sewer MB, Morgan ET. 1998. Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production. J Pharmacol Exp Ther. 287(1):352–358.
   PubMed Web of Science ®Google Scholar
• Sha Y, Marshall HE. 2012. S-nitrosylation in the regulation of gene transcription. Biochim Biophys Acta. 1820(6):701–711.
   PubMed Web of Science ®Google Scholar
• Sharma NK, Kumar A, Kumari A, Tokar EJ, Waalkes MP, Bortner CD, Williams J, Ehrenshaft M, Mason RP, Sinha BK. 2015. Nitric oxide down-regulates topoisomerase I and induces camptothecin resistance in human breast MCF-7 tumor cells. PLoS One. 10(11):e0141897.
   PubMed Web of Science ®Google Scholar
• Shedlofsky SI, Israel BC, McClain CJ, Hill DB, Blouin RA. 1994. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest. 94(6):2209–2214.
   PubMed Web of Science ®Google Scholar
• Siewert E, Bort R, Kluge R, Heinrich PC, Castell J, Jover R. 2000. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent. Hepatology. 32(1):49–55.
   PubMed Web of Science ®Google Scholar
• Smith BC, Fernhoff NB, Marletta MA. 2012. Mechanism and kinetics of inducible nitric oxide synthase auto-S-nitrosation and inactivation. Biochemistry. 51(5):1028–1040.
   PubMed Web of Science ®Google Scholar
• Souza JM, Choi I, Chen Q, Weisse M, Daikhin E, Yudkoff M, Obin M, Ara J, Horwitz J, Ischiropoulos H. 2000. Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys. 380(2):360–366.
   PubMed Web of Science ®Google Scholar
• Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL. 1991. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol. 260(5 Pt 1):C910–C916.
   PubMed Web of Science ®Google Scholar
• Stadler J, Trockfeld J, Schmalix WA, Brill T, Siewert JR, Greim H, Doehmer J. 1994. Inhibition of cytochromes P4501A by nitric oxide. Proc Natl Acad Sci Usa. 91(9):3559–3563.
   PubMed Web of Science ®Google Scholar
• Stamler JS, Lamas S, Fang FC. 2001. Nitrosylation. the prototypic redox-based signaling mechanism. Cell. 106(6):675–683.
   PubMed Web of Science ®Google Scholar
• Stromstedt M, Rozman D, Waterman MR. 1996. The ubiquitously expressed human CYP51 encodes lanosterol 14 alpha-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Arch Biochem Biophys. 329(1):73–81.
   PubMed Web of Science ®Google Scholar
• Sun H, Lee CM, Tripathi S, Kim KB, Morgan ET. 2012. Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2. Biochem J. 445(3):377–382.
   PubMed Web of Science ®Google Scholar
• Takayama F, Egashira T, Yamanaka Y. 1999. NO contribution to lipopolysaccharide-induced hepatic damage in galactosamine-sensitized mice. J Toxicol Sci. 24(1):69–75.
   PubMedGoogle Scholar
• Takemura S, Minamiyama Y, Imaoka S, Funae Y, Hirohashi K, Inoue M, Kinoshita H. 1999. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J Hepatol. 30(6):1035–1044.
   PubMed Web of Science ®Google Scholar
• Tanino T, Komada A, Ueda K, Bando T, Nojiri Y, Ueda Y, Sakurai E. 2016. Pharmacokinetics and differential regulation of cytochrome P450 enzymes in type 1 allergic mice. Drug Metab Dispos. 44(12):1950–1957.
   PubMed Web of Science ®Google Scholar
• Vuppugalla R, Mehvar R. 2004a. Hepatic disposition and effects of nitric oxide donors: rapid and concentration-dependent reduction in the cytochrome P450-mediated drug metabolism in isolated perfused rat livers. J Pharmacol Exp Ther. 310(2):718–727.
   PubMed Web of Science ®Google Scholar
• Vuppugalla R, Mehvar R. 2004b. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: time dependency and reversibility profiles in isolated perfused rat livers. Drug Metab Dispos. 32(12):1446–1454.
   PubMed Web of Science ®Google Scholar
• Vuppugalla R, Mehvar R. 2005. Enzyme-selective effects of nitric oxide on affinity and maximum velocity of various rat cytochromes P450. Drug Metab Dispos. 33(6):829–836.
   PubMed Web of Science ®Google Scholar
• Wang J, Maldonado MA. 2006. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol. 3(4):255–261.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang P, Xu Z, Yue W, Zhuang Y, Chen Y, Lu Z. 2015. S-nitrosylation of PDE5 increases its ubiquitin-proteasomal degradation. Free Radic Biol Med. 86:343–351.
   PubMed Web of Science ®Google Scholar
• Watabe M, Isogai Y, Numazawa S, Yoshida T. 2003. Role of c-Myc in nitric oxide-mediated suppression of cytochrome P450 3A4. Life Sci. 74(1):99–108.
   PubMed Web of Science ®Google Scholar
• Wink DA, Osawa Y, Darbyshire JF, Jones CR, Eshenaur SC, Nims RW. 1993. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys. 300(1):115–123.
   PubMed Web of Science ®Google Scholar
• Yamakura F, Kawasaki H. 2010. Post-translational modifications of superoxide dismutase. Biochim Biophys Acta. 1804(2):318–325.
   PubMed Web of Science ®Google Scholar
• Yin R, Fang L, Li Y, Xue P, Li Y, Guan Y, Chang Y, Chen C, Wang N. 2015. Pro-inflammatory macrophages suppress PPARγ activity in adipocytes via S-nitrosylation. Free Radic Biol Med. 89:895–905.
   PubMed Web of Science ®Google Scholar
• Zhan X, Wang X, Desiderio DM. 2015. Mass spectrometry analysis of nitrotyrosine-containing proteins. Mass Spectrom Rev. 34(4):423–448.
   PubMed Web of Science ®Google Scholar
• Zhang P, Fu WY, Fu AK, Ip NY. 2015. S-nitrosylation-dependent proteasomal degradation restrains Cdk5 activity to regulate hippocampal synaptic strength. Nat Commun. 6:8665.
   PubMed Web of Science ®Google Scholar
• Zhao JF, Jim Leu SJ, Shyue SK, Su KH, Wei J, Lee TS. 2013. Novel effect of paeonol on the formation of foam cells: promotion of LXRα-ABCA1-dependent cholesterol efflux in macrophages. Am J Chin Med. 41(5):1079–1096.
   PubMed Web of Science ®Google Scholar
• Zou M, Martin C, Ullrich V. 1997. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem. 378(7):707–713.
   PubMed Web of Science ®Google Scholar
• Zou MH, Daiber A, Peterson JA, Shoun H, Ullrich V. 2000. Rapid reactions of peroxynitrite with heme-thiolate proteins as the basis for protection of prostacyclin synthase from inactivation by nitration. Arch Biochem Biophys. 376(1):149–155.
   PubMed Web of Science ®Google Scholar
• Zou MH, Klein T, Pasquet JP, Ullrich V. 1998. Interleukin 1beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation. Biochem J. 336(2):507–512.
   PubMed Web of Science ®Google Scholar